Antifungal activity of Caryocar brasiliensis (caryocaraceae) against Cryptococcus neoformans;Atividade antifúngica de Caryocar brasiliensis (caryocaraceae) sobre Cryptococcus neoformans

Revista da Sociedade Brasileira de Medicina Tropical

Volumn 35, Issue 6, 2002, Pages 623-627

  Passos, Xisto Sena ^a   Da Costa Santos, Suzana ^a   Ferri, Pedro Henrique ^a   De Fátima Lisboa Fernandes, Orionalda ^a   De Freitas Paula, Thaliana ^a   Ferreira Garcia, Ana Cristina ^a   Rodrigues Silva, Maria do Rosário ^a  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

Author keywords

Antifungal activity; Caryocar brasiliensis; Cerrado plant; Cryptococcus neoformans

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; PLANT EXTRACT;

ANTIFUNGAL ACTIVITY; ARTICLE; CARYOCAR BRASILIENSIS; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; DRUG EFFECT; HUMAN; IMMUNE DEFICIENCY; MINIMUM INHIBITORY CONCENTRATION; MYCOSIS; NONHUMAN; SCRUB; SIDE EFFECT; TREATMENT OUTCOME;

CARYOCAR; CARYOCARACEAE; FILOBASIDIELLA NEOFORMANS;

EID: 0345700776     PISSN: 00378682     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0037-86822002000600013     Document Type: Article

References (23)

1. Alves SH, Cury AE. Sensibilidade de leveduras do gênero Candida isoladas de pacientes com câncer, a antifúngicos poliênicos. Revista do Instituto de Medicina Tropical de São Paulo 34:251-254, 1992.
2. Alves TMA, Silva AF, Brandão M, Grandi TS, Smânia EF, Smânia Jr. A, Zani CL. Biological screening of Brazilian medicinal plants. Memórias do Instituto Oswaldo Cruz 95:367-373, 2000.
3. Araujo FD. A review of Caryocar brasiliensis (Caryocaraceae) - An economically valuable species of the Central Brazilian Cerrados. Economy Botany 49:40-48, 1995.
4. Cabrera AL, Klein RM. Compostas. Tribo: Vernoniae. In: Reitz. Revista Flora Ilustrada Catarinense. Itajai-SC. Imprensa Oficial do Estado de Santa Catarina 3:224-408, 1980.
5. Canton E, Viudes A, Pemán J. Infección sistémica nosocomial por levaduras. Revista Iberoamericana de Micologia 18:51-55, 2001.
6. Carrillo-Muñoz AJ, Brió S, Quindós G. Una nueva generación de fármacos antifúngicos. Revista Iberoamericana de Micología 18:2-5, 2001.
7. Costa TR, Fernandes OFL, Santos SC, Oliveira CMA, Lião LM, Ferri PH, Paula JR, Ferreira HD, Sales BHN, Silva MRR. Antifungal activity of volatile constituents of Eugenia dysenterica leaf oil. Journal of Ethnopharmacology 72:111-117, 2000.
8. Guimarães DO, Ribeiro JP, Santos SC, Ferri PH, Garcia ACF, Pires JS, Castro ACM, Silva MRR, Ferreira HD. Atividade antifúngica de taninos de Caryocar brasiliensis Camb. In: Resumos da V Jornada Paulista de Plantas Medicinais, Botucatu, p. 158, 2001.
9. Gumbo T, Hakim JG, Mielke J, Siwji S, Just-Nubling G, Ismail A. Cryptococcus myelitis: atypical presentation of a common infection. Clinical Infectious Diseases 32:1235-1236, 2001.
10. Kulberg BJ. Trends in immunotherapy of fungal infections. European Journal of Clinical Microbiology Infectious Diseases 16:51-55, 1997.
11. Negroni R, Arechavala A, Robles AM, Bianchi M, Bava A, Helou S. Revision clínica y evolución terapéutica de pacientes con criptococosis asociada al sida. Revista Iberoamericana de Micología 12:12-15, 1995.
12. Okunade AL, Hufford CD, Richardson MD, Peterson JR, Clark AM. Antimicrobial properties of alkaloids from Xanthorhiza simplicissima. Journal of Pharmaceutical Sciences. 83:404-406, 1994.
13. Passoni LFC. Wood, animals and human beings as reservoirs for human Cryptococcus neoformans infectious. Revista Iberoamericana de Micología 16:77-81, 1999.
14. Passos XS, Costa M, Souza LKH, Miranda ATB, Lemos AA, Ferri PH, Santos SC, Silva MRR. Antifungal activity of Caryocar brasiliensis against Paracoccidioides brasiliensis and Histoplasma capsulatum. Anais do XXI Congresso Brasilieiro de Microbiologia 60:71, 2001.
15. Rozenbaum R, Gonçalves AJR, Wanke B, Vieira W. Cryptococcus neoformans var. gattii in a brasilian AIDS patient. Mycopathologia 112:33-34, 1990.
16. Rubin RH. Infectious disease complications of renal transplantation. Kidney International 44:221-236, 1993.
17. Schoonhoven LM, Jeremy T, Van Loon JJA. Insect-Plant Biology from Physiology to Evolution. Chapman & Hall, London, 1998.
18. Sheelan DJ, Hitchcock CA, Sibley CM. Current and emerging azole antifungal agents. Clinical Microbiology Reviews 12:40-79, 1999.
19. Speed B, Dunt D. Clinical and host differences between infections with the two varieties of Cryptococcus neoformans. Clinical Infectious Diseases 21:28-34, 1995.
20. Sugayama RL, Salatino A. Influence of leaf epicuticular waxes from cerrado species on substrate selection by Atta sexden rubropilosa. Entomologia Experimentalis et Applicata 74:63-69, 1995.
21. Tirillini B, Velasquez ER, Pellegrino R. Chemical composition and antimicrobial activity of essential oil of Piper angustifolium. Planta Medica 62:372-373, 1996.
22. Vanden-Bossche H. Mechanisms of antifungal resistance. Revista Iberoamericana de Micología 14:44-49, 1997.
23. Vander-der Host CM, Saag CM, Cloud GA, Hamill RJ, Graybill J, Sobel JD, Johnson PC, Tuazon CV, Kerkering T, Moskovitz BL, Powderly WG, Dismukes WE. National Institute of Allergy and Infectious Diseases Mycosis Study Group AIDS Clinical Trials Group. Treatment of cryptococcal meningitis associated with the acquired immunodeficiency syndrome. New England Journal of Medical 337:15-21, 1997.